笔记详情
标题
Breast cancer概况
内容
Breast cancer research offers a clinically important venue for exploring resistance to targeted therapy. Antagonists of estrogen receptor–dependent (ER-dependent) and human epidermal growth factor receptor 2 (HER2-dependent) signaling are mainstays of modern breast cancer treatment that enhance cure rates when applied against early-stage disease and contribute to disease remissions when applied against late-stage disease (1, 2).
点击翻译来源
J. Clin. Invest. 118(1): 51-63 (2007)
类别
关键词
